The 2017 Japan Atherosclerosis Society guidelines provide evidence-based recommendations for the prevention of ASCVD through lipid management, drug therapy, and lifestyle modifications.
Answers are grounded in this paper and cite their sources.
Apply 2017 JAS guidelines for ASCVD prevention; extends evidence-based lipid management for clinicians and researchers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kinoshita et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: